Scilex’s premise is simple: the Palo Alto company generates revenue by acquiring, developing, and commercializing non-opioid ...

ZTlido® is a registered trademark owned by Scilex Pharmaceuticals Inc., a wholly-owned subsidiary of Scilex Holding Company. Gloperba® is the subject of an exclusive, transferable license to Scilex ...

Researchers have made a discovery regarding the TRPV1 (transient receptor potential vanilloid 1) ion channel and its role in ...

Researchers from the National University of Singapore (NUS), in collaboration with Peking University, China, have made a discovery regarding the TRPV1 (transient receptor potential vanilloid 1) ion ...

Pharmaceutical and biotech stocks often are seen as steady and safe options for investors for one particular reason. Patients ...

Causes and Impact Postpartum low back pain is a prevalent issue, affecting a significant number of new mothers. This pain ...

Researchers from the National University of Singapore (NUS), in collaboration with Peking University, China, have made a discovery regarding the TRPV1 (transient receptor potential vanilloid 1) ion ...

Asthma affects more than 260M people worldwide and nearly 28M people in the U.S. alone, where, on average, 10 people die from attacks of the chronic disease each day.

ABOUT AK: AK is an ultra-rare, acute, severe parasitic corneal infection caused by acanthamoeba ... It affects people of all ages, most of whom are young or middle-aged soft contact lens wearers.

ZTlido ® is a registered trademark owned by Scilex Pharmaceuticals Inc., a wholly-owned subsidiary of Scilex Holding Company. Gloperba ® is the subject of an exclusive, transferable license to use the ...

In the absence of full guidelines, this expert consensus decision pathway gives practical advice for clinicians.